Modern Authentication of Pharmaceuticals Act of 2025
- Last Action
- 2/6/2025
Actions
- 2025-02-06Referred to the House Committee on Energy and Commerce.
- 2025-02-06Introduced in House
- 2025-02-06Sponsor introductory remarks on measure. (CR H519)
- 2025-02-06Introduced in House
CRS Summary
As of 2025-02-06 (00)
Modern Authentication of Pharmaceuticals Act of 2025
This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.
The bill applies to products manufactured beginning five years after the bill's enactment.
Cosponsors (3)
- John Rutherford (R-FL)
- Don Bacon (R-NE)
- Brian Fitzpatrick (R-PA)
Subjects
- Drug safety, medical device, and laboratory regulation
- Drug trafficking and controlled substances
- Prescription drugs
- Supply chain
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.